Literature DB >> 15681599

Estimation of the time of pulmonary metastasis in colorectal cancer patients with isolated synchronous liver metastasis.

Sotaro Sadahiro1, Toshiyuki Suzuki, Kenji Ishikawa, Tomoki Nakamura, Yoichi Tanaka, Kazuhiro Ishizu, Seiei Yasuda, Hiroyasu Makuuchi, Chieko Murayama.   

Abstract

OBJECTIVE: The aim of this study was to estimate the time when pulmonary metastases began to grow in colorectal cancer (CRC) patients with isolated synchronous liver metastasis based on the tumor doubling time (DT).
METHODS: We examined 23 pulmonary metastases in 14 patients detected after resection of liver metastases from CRC (group 1) and 19 pulmonary metastases in eight patients detected after initiation of hepatic arterial infusion chemotherapy for synchronous unresectable liver metastases (group 2). The regression line was determined from the chest X-ray films, and the DT was calculated.
RESULTS: We estimated the DTs of pulmonary metastases as 65.0 +/- 28.9 and 76.2 +/- 23.0 days in groups 1 and 2, respectively, and the time when pulmonary metastases began to grow as 16-1418 and 112-1464 days before the resection of liver metastases for 19 lesions in 12 out of 14 patients of group 1 and before resection of primary CRC in group 2, respectively.
CONCLUSION: It appears that in some CRC patients in whom the metastatic site is considered to be limited to the liver at diagnosis, occult pulmonary metastasis has already taken place.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681599     DOI: 10.1093/jjco/hyi010

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  2 in total

1.  Biology of colorectal pulmonary metastasis: implications for surgical resection.

Authors:  Michael Poullis; John Littler; John Gosney
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-23

2.  Molecular features and gene expression signature of metastatic colorectal cancer (Review).

Authors:  Martina Poturnajova; Tatiana Furielova; Sona Balintova; Silvia Schmidtova; Lucia Kucerova; Miroslava Matuskova
Journal:  Oncol Rep       Date:  2021-03-02       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.